Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
9.97
-0.10 (-0.99%)
Jul 29, 2026, 4:00 PM EDT - Market closed
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $197.32 million as of July 29, 2026. Its market cap has decreased by -66.52% in one year.
Market Cap
197.32M
Enterprise Value
-68.26M
1-Year Change
-66.52%
Ranking
Category
Stock Price
$9.97
ChartMarket Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $197.32M, a decrease of -48.79%. That is a compound annual growth rate of -10.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 197.32M | -68.19% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 210.08M |
| Conexeu Sciences | 208.45M |
| Cellectis | 207.98M |
| NovaBridge Biosciences | 202.38M |
| Minerva Neurosciences | 199.40M |
| Whitehawk Therapeutics | 197.92M |
| Greenwich LifeSciences | 197.42M |
| Atrium Therapeutics | 196.54M |